Author: Timothé Cynober

Former regulatory scientist at Voisin Consulting Life Sciences in Paris. Currently working in business development at Institut Curie in big data, genomic and bioinformatic tech transfer and industrial partnerships. He describes himself as an innovative tech and therapies addict, interested in innovative health and digital tech, traveling, sports, video games and RPGs, and drawing.

Single-Cell Sequencing Precision Medicine

14/10/2019 7 mins

Single-Cell Sequencing: Paving the Way for Precision Medicine

Artificial Intelligence Cancer

17/06/2019 6 mins

Artificial Intelligence in Oncology: Fantasy or Reality?

CRISPR patents

11/02/2019 4 mins

CRISPR: One Patent to Rule Them All

13/11/2018 6 mins

Biosensors: Monitoring our Health Anywhere, Anytime

14/05/2018 5 mins

Could Stem Cells Replace Animal Testing in Drug Development?

04/04/2018 5 mins

Why Are There Only 10 Cell and Gene Therapies in Europe?

20/12/2017 5 mins

How to Deal with Regulations to Get Approval for CAR-T Cells

20/07/2017 4 mins

SHIVA Trial: France’s Big Shot at Precision Medicine for Cancer

12/07/2017 4 mins

Genomic Testing in Oncology: From Single Genes to Whole Genomes

14/06/2017 4 mins

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

18/01/2017 6 mins

It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail

08/09/2016 4 mins

Stem Cell Tourism makes Big Promises but may End your Life…

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.